EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Reportaap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements27-Jun-2025 / 18:22 CET/CESTDisclosure of an inside information acc. On November 18, 2024, aap Implantate AG (“Company”) announced in an ad hoc announcement that EBITDA for the fiscal year 2024 was expected to be between EUR -0.5 million and EUR 0.5 million. Contrary to the raised forecast, the Company's EBITDA for the 2024 fiscal year will amount to EUR -0.85 million. However, on Monday, June 30, 2025, the company will publish preliminary, unaudited financial information for the Group for the 2024 fiscal year in addition to the publication of the audited annual financial statements (individual financial statements). Contact:If you have any questions, please contact:aap Implantate AG; R. Di Girolamo; Chairman of the Management Board / CEO; Lorenzweg 5;D-12099 Berlin, Tel.